Concepedia

N Ishizuka

NI

Statistics

Publications

21

Citations

551

H-Index

16

Active since

1962

Affiliations

Chugai Pharma (United States)(Current)

Tokai University

Graduate Hospital

N Ishizuka is an author at Chugai Pharma (United States) specializing in medicine, pharmacology, and nicorandil therapy.

ORCID

Publications per year

1962–2016

21

Publications

21

Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan

Ken Nakajima, Omi Watanabe, Mayumi Mochizuki et al. · Modern Rheumatology · 2016 · 97 citations · Full text

, , +8

Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats

Kenichi Serizawa, Kenji Yogo, Ken Aizawa et al. · Cardiovascular Diabetology · 2011 · 64 citations · Full text

, , +15

Nicorandil and Leukocyte Activation

Takanori Yasu, Nahoko Ikeda, N Ishizuka et al. · Journal of Cardiovascular Pharmacology · 2002 · 36 citations

, , +15

Pregnancy and childbirth in a true hermaphrodite.

O Narita, S Manba, Tamao Nakanishi et al. · PubMed · 1975 · 35 citations

, , +13

Nicorandil Attenuates FeCl3-Induced Thrombus Formation Through the Inhibition of Reactive Oxygen Species Production

Yu Eguchi, Youko Takahari, Naoko Higashijima et al. · Circulation Journal · 2009 · 29 citations · Full text

, , +17

1–5 of 21